The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Dosing Frequency and Medication Adherence in Chronic Disease
Open accessAbstract
BACKGROUND: Prior research has shown a decrease in medication adherence as dosing frequency increases; however, meta-analyses have not been able to demonstrate a significant inverse relationship between dosing frequency and adherence when comparing twice-daily versus once-daily dosing. OBJECTIVE: To determine the effect of scheduled dosing frequency on medication adherence in patients with chronic diseases. METHODS: A systematic literature search of Medline and Embase from January 1986 to December 2011 and a hand search of references were performed to identify eligible studies. Randomized and observational studies were included if they utilized a prospective design, assessed adult patients with chronic diseases, evaluated scheduled oral medications taken 1 to 4 times daily, and measured medication adherence for at least 1 month using an electronic monitoring device. Manual searches of reference sections of identified studies and systematic reviews were also performed to find other potentially relevant articles. Standard definitions for medication taking, regimen, and timing adherence were used and evaluated. Studies were pooled using a multivariate linear mixed-model method to conduct meta-regression accounting for both random and fixed effects, weighted by the inverse of the variance of medication adherence. RESULTS: Fifty-one studies, comprising 65, 76, and 47 dosing frequency arms for the taking, regimen, and timing adherence endpoints were included. Unadjusted adherence estimates were highest when the least stringent definition, taking adherence, was used (range for dosing frequencies: 80.1%-93.0%) and lowest when the most stringent definition, timing adherence, was used (range for dosing frequencies: 18.8%-76.9%). In multivariate meta-regression analyses, the adjusted weighted mean percentage adherence rates for all regimens dosed more frequently than once per day were significantly lower compared with once-daily regimens (for 2-times, 3-times, and 4-times daily regimens, respectively: differences for taking adherence: -6.7%, -13.5%, and -19.2%; regimen adherence: -13.1%, -24.9%, and -23.1%; and timing adherence: -26.7%, -39.0%, and -54.2%). CONCLUSION: Patients with chronic diseases appear to be more adherent with once-daily compared with more frequently scheduled medication regimens. The use of more stringent definitions of adherence magnified these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
A systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
How often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,021
The Effect of Prescribed Daily Dose Frequency on Patient Medication Compliance
Eisen, S. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.9.1881 · Cited by 817
Brian Haynes, R., Ann McKibbon, K., & Kanani, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01073-2 · Cited by 645
Persistence of Use of Lipid-Lowering Medications: A Cross-National Study
Avorn, J., Monette, J., Lacour, A., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 634
Hospital Admissions Resulting from Preventable Adverse Drug Reactions
McDonnell, P. J., & Jacobs, M. R. (2002) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2002)036<1331:harfpa>2.0.co;2 · Cited by 587
Impact of Dosage Frequency on Patient Compliance
Paes, A. H. P., Bakker, A., & Soe-Agnie, C. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1512 · Cited by 408
(2009) · PubMed · Cited by 359
Clowes, J. A., Peel, N. F. A., & Eastell, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030501 · Cited by 334
Senst, B. L., Achusim, L. E., Genest, R. P., Cosentino, L. A., Ford, C. C., Little, J. A., Raybon, S. J., & Bates, D. W. (2001) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/58.12.1126 · Cited by 309
Medication compliance: a healthcare problem.
Berg, J. S., Dischler, J. E., Wagner, D. J., Raia, J., & Palmer-Shevlin, N. L. (1993) · PubMed · Cited by 272
Decompensated heart failure: symptoms, patterns of onset, and contributing factors
Schiff, G. D., Fung, S., Speroff, T., & McNutt, R. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00132-3 · Cited by 255
The impact of cognitive function on medication management: Three studies.
Stilley, C. S., Bender, C. M., Dunbar-Jacob, J., Sereika, S., & Ryan, C. M. (2010) · Health Psychology · doi:10.1037/a0016940 · Cited by 248
A multivariate mixed linear model for meta-analysis.
Kalaian, H. A., & Raudenbush, S. W. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.3.227 · Cited by 229 · cited 3×
“In an attempt to overcome these obstacles, we conducted a multivariate meta-regression analysis to adjust for multiple study-level characteristics.(4) However, it is unlikely we were able to adjust for all important sources of heterogeneity between studies, and we cannot rule out the presence of residual confounding.”
BackgroundMethodInfluentialAdherence to antiparkinson medication in a multicenter European study
Grosset, D., Antonini, A., Canesi, M., Pezzoli, G., Lees, A., Shaw, K., Cubo, E., Martinez‐Martin, P., Rascol, O., Negre‐Pages, L., et al. (2009) · Movement Disorders · doi:10.1002/mds.22112 · Cited by 171
The Significance of Continuous Dopaminergic Stimulation in the Treatment of Parkinson??s Disease
Chase, T. N. (1998) · Drugs · doi:10.2165/00003495-199855001-00001 · Cited by 167
Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk, E., van der Heijde, D. M. F. M., Landewé, R., van der Tempel, H., Urquhart, J., & van der Linden, S. (2003) · PubMed · Cited by 157
Measuring Adherence in a Hypertension Clinical Trial
Hamilton, G. A. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00058-6 · Cited by 144
Dynamics of drug regimen compliance ? its assessment by microprocessor-based monitoring
Kruse, W., & Weber, E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278582 · Cited by 131
Benefits of adherence to anti-hypertensive drug therapy
Flack, J. M., Novikov, S. V., & Ferrario, C. M. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_a.16 · Cited by 129
Adherence to Pharmacologic Management of Hypertension
Feldman, R. D., Bacher, M., Campbell, N. R. C., Drover, A., & Chockalingam, A. (1998) · Canadian Journal of Public Health · doi:10.1007/bf03404494 · Cited by 124
Leenen, F. H. H., Wilson, T. W., Bolli, P., Larochelle, P. M., Myers, M. G., Handa, S., Boileau, G., & Tanner, J. (1997) · PubMed · Cited by 121
Cramer, J. A., Vachon, L., Desforges, C., & Sussman, N. M. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00469.x · Cited by 120
Comparing compliance patterns between randomized treatments
Vrijens, B., & Goetghebeur, E. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00235-8 · Cited by 114
Noncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better
Mulleners, W., Whitmarsh, T., & Steiner, T. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1801052.x · Cited by 94
Kruse, W., Rampmaier, J., Ullrich, G., & Weber, E. (1994) · PubMed · Cited by 90
Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study
Waeber, B., Leonetti, G., Kolloch, R. E., & McInnes, G. T. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917070-00022 · Cited by 83
Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice
Schwed, A., Stubi, C.-L. F., Burnier, M., Waeber, B., KAPPENBERGER, L. J., Burnand, B., & Darioli, R. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007976 · Cited by 78
Compliance, electronic monitoring and antihypertensive drugs.
Mallion, J.-M., Baguet, J.-P., Siche, J. P., Tremel, F., & Gaudemaris, R. D. (1998) · PubMed · Cited by 77
Grosset, K. A., & Grosset, D. G. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-20 · Cited by 76
Adherence to Angiotensin‐Converting Enzyme Inhibitor Therapy for Heart Failure
Bohachick, P., Burke, L. E., Sereika, S. M., Murali, S., & Dunbar‐Jacob, J. M. (2002) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2002.01643.x · Cited by 65
Kardas, P. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00462.x · Cited by 64
Effects of nonadherence with prescription drugs among older adults.
Butler, R., Davis, T. K., Johnson, W. G., & Gardner, H. H. (2011) · PubMed · Cited by 62
Quenet, S., Buchmüller-Cordier, A., Reynaud, J., Tardy-Poncet, B., Thirion, C., Decousus, H., Mismetti, P., & Laporte, S. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613374 · Cited by 61
Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas
Winkler, A., & Teuscher, A. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.10036 · Cited by 61
The effect of medication compliance on the control of hypertension
Eisen, S. A., Woodward, R. S., Miller, D. K., Spitznagel, E., & Windham, C. A. (1987) · Journal of General Internal Medicine · doi:10.1007/bf02596162 · Cited by 61
Mallion, J. M., Dutrey-Dupagne, C., Vaur, L., Genès, N., Renault, M., Elkik, F., Baguet, P., & Boutelant, S. (1996) · PubMed · Cited by 53
IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY
Waeber, B., Vetter, W., Dariolp, R., Keller, U. B., & Hr, B. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11657.x · Cited by 50
de Klerk, E., & van der Linden, S. (1996) · Rheumatology · doi:10.1093/rheumatology/35.1.60 · Cited by 44
Udelson, J. E., Pressler, S. J., Sackner‐Bernstein, J., Massaro, J. M., Ordronneau, P., Lukas, M. A., & Hauptman, P. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.12.010 · Cited by 43
Comparison of once daily versus twice daily oral nitrates in stable angina pectoris
Kardas, P. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.067 · Cited by 41
Clerisme-Beaty, E. M., Bartlett, S. J., Teague, W. G., Lima, J. J., Irvin, C. G., Cohen, R. I., Castro, M., Wise, R. A., & Rand, C. S. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.038 · Cited by 41
Medication management by the person with epilepsy: perception versus reality
Buelow, J. M., & Smith, M. C. F. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.02.002 · Cited by 40
Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis
Yentzer, B. A., Yelverton, C. B., Pearce, D. J., Camacho, F., Makhzoumi, Z. H., Clark, A. R., Boles, A., Fleischer, A. B., Balkrishnan, R., & Feldman, S. R. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.007 · Cited by 39
Kardas, P. (2007) · Vascular Health and Risk Management · doi:10.2147/vhrm.2007.3.2.235 · Cited by 38
Developing compliance instructions for drug labeling
Levy, G. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110976 · Cited by 37
Gaps in cardiovascular medication taking: The tip of the iceberg
Rudd, P., Ramesh, J., Bryant-Kosling, C., & Guerrero, D. (1993) · Journal of General Internal Medicine · doi:10.1007/bf02598282 · Cited by 36
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance
Charpentier, G., Fleury, F., Dubroca, I., Vaur, L., & Clerson, P. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70185-4 · Cited by 35
Compliance with an oral asthma medication: a pilot study using an electronic monitoring device
Chung, K. F., & Naya, I. P. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0813 · Cited by 34
Brun, J. (1994) · Journal of International Medical Research · doi:10.1177/030006059402200503 · Cited by 32
Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring
Kruse, W., Nikolaus, T., Rampmaier, J., Weber, E., & Schlierf, G. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315385 · Cited by 31
Girvin, B., & Johnston, G. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000125440.28861.d6 · Cited by 28
Favrat, B., Vaucher, P., Herzig, L., Burnand, B., Ali, G., Boulat, O., Bischoff, T., & Verdon, F. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-2 · Cited by 27
Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study
Doró, P., Benkő, R., Czakó, A., Matúz, M., Thurzó, F., & Soós, G. (2011) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-011-9529-7 · Cited by 23
Straka, R. J., Fish, J. T., Benson, S. R., & Suh, J. T. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04222.x · Cited by 20
Cited by
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
“43,44 Beyond the influence of dosing schedules, recent data suggest that the overall complexity of the T2D medication regimen predicts adherence, with greater complexity contributing to poorer adherence.”
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
Covalent inhibitors: a rational approach to drug discovery
Sutanto, F., Konstantinidou, M., & Dömling, A. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00154f · Cited by 389
Vermersch, P., Czlonkowska, A., Grimaldi, L. M., Confavreux, C., Comi, G., Kappos, L., Olsson, T. P., Benamor, M., Bauer, D., Truffinet, P., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513507821 · Cited by 354
Metadata
- Authors
- Coleman, C. I., Limone, B., Sobieraj, D. M., Lee, S., Roberts, M. S., Kaur, R., & Alam, T.
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2012-09
- Volume
- 18
- Issue
- 7
- Pages
- 527-539
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- OpenAlex
- W2235318197
- Cited by
- 432
- References
- 58
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.